Device type · MTA
Lens, Intraocular, Phakic
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
MTA
Ophthalmic
Device class
Class III
FDA decisions since 2015
1
510(k), De Novo and PMA
Adverse event reports
811
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Lens, Intraocular, Phakic
- Product code
- MTA
- Device class
- Class III
- Review panel
- Ophthalmic
- Specialty
- Ophthalmology
- FDA record
- Classification database entry for MTA
Latest FDA decisions
- EVO/EVO+VISIAN Implantable Collamer LensPMA supplement
P030016-S035 · Decided Mar 25, 2022 · 1,240 days after receipt · Panel Track
Device type: Lens, intraocular, phakic (MTA) · Ophthalmology
Reports received
811
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
60
7.4% of reports
Injury reports
751
93% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 47 | 136 | 0 | 0 |
| Jan 24 | 45 | 120 | 0 | 0 |
| Feb 24 | 50 | 128 | 0 | 0 |
| Mar 24 | 41 | 138 | 0 | 0 |
| Apr 24 | 48 | 154 | 0 | 0 |
| May 24 | 60 | 122 | 0 | 0 |
| Jun 24 | 36 | 110 | 0 | 0 |
| Jul 24 | 40 | 136 | 0 | 0 |
| Aug 24 | 36 | 192 | 0 | 0 |
| Sep 24 | 39 | 160 | 0 | 0 |
| Oct 24 | 36 | 128 | 0 | 0 |
| Nov 24 | 40 | 117 | 0 | 0 |
| Dec 24 | 18 | 152 | 0 | 0 |
| Jan 25 | 0 | 70 | 0 | 0 |
| Feb 25 | 0 | 50 | 0 | 0 |
| Mar 25 | 0 | 56 | 0 | 0 |
| Apr 25 | 0 | 47 | 0 | 0 |
| May 25 | 0 | 37 | 0 | 0 |
| Jun 25 | 0 | 42 | 0 | 0 |
| Jul 25 | 0 | 57 | 0 | 0 |
| Aug 25 | 0 | 49 | 0 | 0 |
| Sep 25 | 0 | 53 | 0 | 0 |
| Oct 25 | 0 | 67 | 0 | 0 |
| Nov 25 | 0 | 51 | 0 | 0 |
| Dec 25 | 0 | 78 | 0 | 0 |
| Jan 26 | 0 | 42 | 0 | 0 |
| Feb 26 | 1 | 67 | 0 | 0 |
| Mar 26 | 0 | 59 | 0 | 0 |
| Apr 26 | 3 | 66 | 0 | 0 |
| May 26 | 5 | 67 | 0 | 0 |
| Jun 26 | 3 | 76 | 0 | 0 |
| Jul 26 | 30 | 59 | 0 | 0 |
| Aug 26 | 17 | 74 | 0 | 0 |
| Sep 26 | 1 | 49 | 0 | 0 |
| Oct 26 | 0 | 63 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Adverse Event Without Identified Device or Use Problem752
- No Apparent Adverse Event58
- Product Quality Problem1
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available331
- Blurred Vision205
- No Clinical Signs, Symptoms or Conditions123
- Intraocular Pressure Increased67
- Visual Disturbances58
- Cataract42
- Halo35
- Uveitis31
- Inflammation24
- Iritis18
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2509-2026 · Started Apr 20, 2026 · Posted by FDA Jun 18, 2026
Reason given: Due to a software coding issues for calculating the implant orientation diagram printout for the implantation for toric implantable collamer lenses.
Cause as FDA categorized it: Software design
Z-0464-2024 · Started Sep 29, 2023 · Posted by FDA Dec 1, 2023
Reason given: Their is a potential that intraocular implant devices may not meet specifications.
Cause as FDA categorized it: Software design (manufacturing process)
Z-0465-2024 · Started Sep 29, 2023 · Posted by FDA Dec 1, 2023
Reason given: Their is a potential that intraocular implant devices may not meet specifications.
Cause as FDA categorized it: Software design (manufacturing process)
Z-0466-2024 · Started Sep 29, 2023 · Posted by FDA Dec 1, 2023
Reason given: Their is a potential that intraocular implant devices may not meet specifications.
Cause as FDA categorized it: Software design (manufacturing process)
Z-0467-2024 · Started Sep 29, 2023 · Posted by FDA Dec 1, 2023
Reason given: Their is a potential that intraocular implant devices may not meet specifications.
Cause as FDA categorized it: Software design (manufacturing process)
Z-0468-2024 · Started Sep 29, 2023 · Posted by FDA Dec 1, 2023
Reason given: Their is a potential that intraocular implant devices may not meet specifications.
Cause as FDA categorized it: Software design (manufacturing process)
Z-0469-2024 · Started Sep 29, 2023 · Posted by FDA Dec 1, 2023
Reason given: Their is a potential that intraocular implant devices may not meet specifications.
Cause as FDA categorized it: Software design (manufacturing process)
Z-0474-2024 · Started Sep 29, 2023 · Posted by FDA Dec 1, 2023
Reason given: Their is a potential that intraocular implant devices may not meet specifications.
Cause as FDA categorized it: Software design (manufacturing process)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.